It doesn’t take much to understand the political and economic BS that is out there guiding you down the wrong path. Let’s not write about – or talk about it. Let’s just let the images speak for myself and many Americans. ~ Editor

Continue reading →

Global central banks on a cumulative basis have never sold gold between 2010 and 2022

The US dollar has been the de-facto world reserve currency for more than half a century, with no questions asked about the greenback’s exceptionalism. However, the Ukraine war potentially begets an inflection point wherein nations are endeavoring for a multipolar world. Countries are now increasingly finding an alternative to settle trades in other currencies. Continue reading →

It won’t be long before governments around the world, including the one in Washington – self-destruct.

Strong words, but anything less would be naïve.

As economist Herbert Stein once said, “If something cannot go on forever, it has a tendency to stop.” Case in point: fiat money political regimes. Interventionist economies of the West are in a fatal downward spiral, comparable to that of the Roman Empire in the second century, burdened with unsustainable debt and the antiprosperity policies of governments, especially the Green New Deal. Continue reading →

It feels like a silly thing to say, but board games are not real life. Playing a few rounds of Operation does not make you a surgeon. Unlike in Battleship, real-world battleships do not sit still on a ten-by-ten grid. Continue reading →

Growing optimism that the U.S. economy can avoid a severe recession even as the Federal Reserve maintains its hawkish bias continues to weigh on the gold market as prices trade near a six-month low.

However, analysts at the Australian-based bank ANZ said that despite short-term selling pressure, they are maintaining their bullish medium to long-term outlook on the precious metal. Daniel Hynes, senior commodity strategist and the lead author of their latest report, said that while he can’t rule out a drop below $1,900, he does see signs of solid support in the marketplace. Continue reading →

The price of a McDonald’s hamburger in the United States has inflated 3.75 percent annually over the last seventy years. McDonald’s has grown from a tiny hamburger stand in Des Plaines, Illinois, to the second largest fast-food chain on earth. Scale economies alone (never mind process and productivity improvements) should’ve allowed the price of a burger to decline materially over this period.

Why didn’t it? What forces and institutions have conspired to inflate the cost of a simple meal by more than thirteen times over two generations? Continue reading →

The conventional wisdom about Friday’s disappointing jobs data was that there was a little something for everyone. And, for once… the conventional wisdom is right…

They are called ‘Blow‘ – Jobs Joey!

The headline jobs number fell below Wall Street’s expectations, suggesting a softening of the labor market. The average workweek slipped as well, which is often the first sign of an employment downturn. Employers tend to reduce hours of their workforce before they start actually sending out the pink slips.

On the surface, this is bad news for the Biden campaign, which has hitched its wagon to the far-flung notion that the Biden presidency has been a blessing for the American economy. Weakening job growth makes that a harder sell – as would the spread of labor strife from Hollywood to the UAW. Continue reading →

The partnership could be bad news for pharmacy benefit managers

Little by little, pharmacy benefit managers (PBMs) are getting their comeuppance and American consumers are getting their due when it comes to the cost of prescription drugs.

Mark Cuban’s Cost Plus Drugs has cut a deal with Kroger that will give consumers in 35 states the power to find the lowest price for a prescription drug.

Anyone who’s watched ‘Shark Tank’ knows that Cuban is a take-no-prisoners kind of guy and he apparently sees an opportunity when it comes to high-priced drugs.

The Cost Plus business model is simple. It marks up each drug by 15% and adds a $3 pharmacy fee where applicable. The company makes a profit and customers can finally get their prescriptions filled without taking out a loan. (Continue to full column…)